Skip to content

Integer Holdings ITGR PP&E Sale Proceeds

PP&E Sale Proceeds at other companies

Haemonetics logo
HaemoneticsHAE
$526K-78.5%
ICU Medical logo
ICU MedicalICUI
$1K-97.6%
Novanta logo
NovantaNOVT
$345K-93.8%

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$3.04B-27.0%
Enterprise value$4.41B-19.6%
P/E21.4×-32.8×
P/S1.6×-0.7×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment.

The official record: Integer Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integer Holdings's pp&e sale proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integer Holdings's PP&E sale proceeds?
Integer Holdings (ITGR) reported PP&E sale proceeds of $55K in Q1 2026.
How has Integer Holdings's PP&E sale proceeds changed year-over-year?
Integer Holdings's PP&E sale proceeds increased by 1000.0% year-over-year, from $5K to $55K.
What is the long-term trend for Integer Holdings's PP&E sale proceeds?
Over 3 years (2021 to 2024), Integer Holdings's PP&E sale proceeds has grown at a -55.5% compound annual growth rate (CAGR), from $443K to $39K.
What does PP&E sale proceeds mean?
Cash received from selling property, plant, and equipment no longer needed for operations.